Pharmacokinetic variability due to environmental differences

Area of Science:

• Pharmacokinetics
• Drug Metabolism
• Clinical Pharmacology

Background:

• Pharmacokinetic variability significantly affects drug efficacy and safety.
• Genetic factors are well-studied, but non-genetic influences require further elucidation.
• Environmental factors represent a substantial, often underestimated, source of drug variability.

Purpose of the Study:

• To review non-genetic sources of pharmacokinetic variability.
• To highlight key environmental factors influencing drug disposition.
• To emphasize the clinical relevance of these factors in patient care.

Main Methods:

• Literature review of pharmacokinetic variability.
• Analysis of environmental factors impacting drug absorption, distribution, metabolism, and excretion.
• Synthesis of data on body size, maturation, and organ function.

Main Results:

• Body size and composition are crucial determinants of drug pharmacokinetics across all patient populations.
• Maturation significantly alters pharmacokinetics, especially in neonates and infants (<2 years).
• Renal function emerges as the most critical predictable source of pharmacokinetic variability due to organ function differences.

Conclusions:

• Environmental factors, beyond genetics, are major drivers of pharmacokinetic variability.
• Clinicians must consider patient size, age-related maturation, and organ function for optimal drug dosing.
• Understanding these environmental influences is essential for personalized medicine and improved therapeutic outcomes.